LexisNexis Patent Law Community | LexisNexis
Featured Content
  • Add content to My Page

    Select any content type from the list, once selected it will be automatically added to your 'My Page'.


    You are not logged in. Please Login to add content to your community page

02/08/2013 04:45:35 PM EST

Fed. Circ. Erred On Allergy Drug Claims, Novartis Says

Posted by

Law360: Intellectual Property

Novartis AG’s Alcon Inc. unit on Friday urged the U.S. Supreme Court to reverse a Federal Circuit ruling that stripped patent protection for its allergy drug Pataday, arguing that the appeals court’s finding on claim construction goes against Federal Read More...